α-Synuclein forms a complex with transcription factor Elk-1

Journal of Neurochemistry

Volumn 77, Issue 1, 2001, Pages 239-252

  Iwata, Atsushi ^a,b   Miura, Seiko ^a   Kanazawa, Ichiro ^b   Sawada, Makoto ^c   Nukina, Nobuyuki ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

synuclein; Elk 1; ERK 2; Multiple system atrophy; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL INCLUSION; CELL LYSATE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LEWY BODY; NERVE CELL; NERVE DEGENERATION; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SHY DRAGER SYNDROME;

ALPHA-SYNUCLEIN; AMINO ACID MOTIFS; ANIMALS; BINDING SITES; CELL LINE; CYTOPLASMIC GRANULES; DNA-BINDING PROTEINS; ETS-DOMAIN PROTEIN ELK-1; HUMANS; LEWY BODY DISEASE; MACROMOLECULAR SUBSTANCES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MULTIPLE SYSTEM ATROPHY; MUTAGENESIS, SITE-DIRECTED; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; PARKINSON DISEASE; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; SYNUCLEINS; TRANSCRIPTION FACTORS; TRANSFECTION;

ANIMALIA; CERVUS ELAPHUS;

EID: 0035076647     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00232.x     Document Type: Article

References (39)

1. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
2. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 1. Neuronal cytoplasmic inclusions
3. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
4. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
5. The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factor
6. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation
7. Widespread alterations of alpha-synuclein in multiple system atrophy
8. A Drosophila model of Parkinson's disease
9. Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components
10. Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro
11. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation
12. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha- synuclein in vitro
13. Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease
14. Functional analysis of a growth factor-responsive transcription factor complex
15. Transcriptional regulation by extracellular signals: Mechanisms and specificity
16. Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2
17. Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: Immunohistochemical and ultrastructural studies
18. Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2
19. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
20. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain
21. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders
22. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 2. Oligodendroglial cytoplasmic inclusions
23. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation
24. Establishment of mouse oligodendrocyte/type-2 astrocyte lineage cell line by transfection with origin-defective simian virus 40 DNA
25. Copper (II)-induced self-oligomerization of alpha-synuclein
26. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)
27. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
28. Cell death mechanisms in multiple system atrophy
29. ERK2/p42 MAP kinase stimulates both autonomous and SRF-dependent DNA binding by Elk-1
30. The transcription factors Elk-1 and serum response factor interact by direct protein-protein contacts mediated by a short region of Elk-1
31. Alpha-synuclein in Lewy bodies
32. Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies
33. Synoretin - A new protein belonging to the synuclein family
34. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein
35. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy
36. Alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease
37. Structural organization of the human Elk1 gene and its processed pseudogene Elk2
38. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1
39. The mechanism of phosphorylation-inducible activation of the ETS-domain transcription factor Elk-1